• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康素养与累积社会劣势与肝细胞癌患者的生存及移植相关:一项前瞻性研究。

Health literacy and cumulative social disadvantage are associated with survival and transplant in patients with hepatocellular carcinoma: a prospective study.

作者信息

Nephew Lauren D, Rawl Susan M, Carter Allie, Garcia Nicole, Monahan Patrick O, Holden John, Ghabril Marwan, Montalvan-Sanchez Eleazar, Patidar Kavish, Desai Archita P, Orman Eric, Chalasani Naga

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA

Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.

出版信息

BMJ Open Gastroenterol. 2024 Oct 2;11(1):e001537. doi: 10.1136/bmjgast-2024-001537.

DOI:10.1136/bmjgast-2024-001537
PMID:39357929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11448155/
Abstract

OBJECTIVE

To investigate how individual social determinants of health (SDOH) and cumulative social disadvantage (CSD) affect survival and receipt of liver transplant (LT) in patients with hepatocellular carcinoma (HCC).

METHODS

We enrolled 139 adult patients from two Indianapolis hospital systems between June 2019 and April 2022. Structured questionnaires collected SDOH and social risk factor data. We compared SDOH and CSD by race, gender and disease aetiology, assigning one point per adverse SDOH. Multivariable competing risk survival analysis assessed associations between SDOH, CSD, survival and LT receipt.

RESULTS

Black patients experienced higher CSD than white patients in the cohort (5.4±2.5 vs 3.2±2.1, p<0.001). Black patients were significantly more likely to have household incomes <US$15 000 per year (52.6% vs 18.3%, p=0.003), to be insured by Medicaid (57.9% vs 33.0%, p=0.04), and to live in high Social Deprivation Index areas (68.4% vs 17.5%, p<0.001) than white patients. Patients with hepatitis C virus and alcohol-related liver disease had more adverse SDOH than those with metabolic dysfunction-associated steatotic liver disease, while there were no significant differences by gender. On multivariable analysis, a higher health literacy score was a significant predictor of survival (HR 2.54, 95% CI 1.19 to 5.43 CI, p=0.02) and higher CSD was associated with a lower probability of receipt of LT (HR 0.80, 95% CI 0.68 to 0.95, p=0.01).

CONCLUSIONS

There are significant racial and aetiology-related differences in SDOH burden. Low health literacy and high CSD are linked to worse outcomes in HCC patients. Health literacy screening and targeted interventions for those with high CSD could improve LT access and survival rates.

摘要

目的

探讨个体健康的社会决定因素(SDOH)和累积社会劣势(CSD)如何影响肝细胞癌(HCC)患者的生存及肝移植(LT)接受情况。

方法

2019年6月至2022年4月期间,我们从印第安纳波利斯的两个医院系统招募了139例成年患者。通过结构化问卷收集SDOH和社会风险因素数据。我们按种族、性别和疾病病因比较SDOH和CSD,每个不利的SDOH因素计1分。多变量竞争风险生存分析评估SDOH、CSD、生存和LT接受之间的关联。

结果

队列中黑人患者的CSD高于白人患者(5.4±2.5对3.2±2.1,p<0.001)。黑人患者家庭年收入低于15000美元的可能性显著更高(52.6%对18.3%,p=0.003),由医疗补助保险的可能性更高(57.9%对33.0%,p=0.04),且居住在社会剥夺指数高的地区的可能性高于白人患者(68.4%对17.5%,p<0.001)。丙型肝炎病毒和酒精性肝病患者的不利SDOH因素比代谢功能障碍相关脂肪性肝病患者更多,而性别之间无显著差异。多变量分析显示,较高的健康素养得分是生存的显著预测因素(风险比[HR]2.54,95%置信区间[CI]1.19至5.43,p=0.02),较高的CSD与接受LT的概率较低相关(HR 0.80,95%CI 0.68至0.95,p=0.01)。

结论

SDOH负担存在显著的种族和病因相关差异。低健康素养和高CSD与HCC患者的不良结局相关。对高CSD患者进行健康素养筛查和有针对性的干预可改善LT的可及性和生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a8/11448155/bbd3ba7cf92c/bmjgast-11-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a8/11448155/ff01ba870874/bmjgast-11-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a8/11448155/8f5da9cce892/bmjgast-11-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a8/11448155/bbd3ba7cf92c/bmjgast-11-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a8/11448155/ff01ba870874/bmjgast-11-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a8/11448155/8f5da9cce892/bmjgast-11-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a8/11448155/bbd3ba7cf92c/bmjgast-11-1-g003.jpg

相似文献

1
Health literacy and cumulative social disadvantage are associated with survival and transplant in patients with hepatocellular carcinoma: a prospective study.健康素养与累积社会劣势与肝细胞癌患者的生存及移植相关:一项前瞻性研究。
BMJ Open Gastroenterol. 2024 Oct 2;11(1):e001537. doi: 10.1136/bmjgast-2024-001537.
2
Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.比较公共医疗保险与私人医疗保险患者的肝癌肝移植候补名单结果。
JAMA Netw Open. 2019 Aug 2;2(8):e1910326. doi: 10.1001/jamanetworkopen.2019.10326.
3
Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change.肝癌患者在等待 6 个月政策改变后接受肝移植的种族差异。
JAMA Netw Open. 2023 Nov 1;6(11):e2341096. doi: 10.1001/jamanetworkopen.2023.41096.
4
Association between social determinants of health and survival among the US cancer survivors population.社会决定因素与美国癌症幸存者人群生存状况的关联。
BMC Med. 2024 Aug 26;22(1):343. doi: 10.1186/s12916-024-03563-0.
5
Racial-ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy.种族和民族差异在肝癌患者肝移植候补名单结果中的作用:在分配政策最近改变前后。
Clin Transplant. 2024 Jun;38(6):e15365. doi: 10.1111/ctr.15365.
6
Neighborhood-level social determinants of health measures independently predict receipt of living donor liver transplantation in the United States.社区层面的健康决定因素指标可独立预测在美国接受活体供肝移植的情况。
Liver Transpl. 2024 Jun 1;30(6):618-627. doi: 10.1097/LVT.0000000000000313. Epub 2023 Dec 18.
7
Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.等待时间可预测肝细胞癌肝移植后的生存率:一项使用器官共享联合网络登记处的队列研究。
Liver Transpl. 2014 Sep;20(9):1045-56. doi: 10.1002/lt.23917. Epub 2014 Aug 4.
8
Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.糖尿病可能影响乙型肝炎病毒相关肝细胞癌患者肝移植后的长期生存。
World J Gastroenterol. 2016 Nov 21;22(43):9571-9585. doi: 10.3748/wjg.v22.i43.9571.
9
Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.非酒精性脂肪性肝炎肝细胞癌患者接受终末期肝病模型例外情况的比例较低,且移植等待时间较长。
Liver Transpl. 2016 Oct;22(10):1356-66. doi: 10.1002/lt.24507.
10
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.HALT-HCC 评分的开发和验证:用于预测肝癌肝移植受者死亡率的回顾性队列分析。
Lancet Gastroenterol Hepatol. 2017 Aug;2(8):595-603. doi: 10.1016/S2468-1253(17)30106-1. Epub 2017 May 22.

引用本文的文献

1
Educational, financial, logistical, emotional, and social needs among patients with hepatocellular carcinoma.肝细胞癌患者的教育、经济、后勤、情感和社会需求。
Hepatol Commun. 2025 Jul 21;9(8). doi: 10.1097/HC9.0000000000000739. eCollection 2025 Aug 1.
2
Feasible and acceptable social drivers of health screening among patients with chronic liver disease.慢性肝病患者健康筛查中可行且可接受的社会驱动因素。
Hepatol Commun. 2025 Jun 30;9(7). doi: 10.1097/HC9.0000000000000758. eCollection 2025 Jul 1.
3
The Role of Patient-Reported Outcomes in Cirrhosis.

本文引用的文献

1
Cumulative social disadvantage and health-related quality of life: national health interview survey 2013-2017.累积的社会劣势与健康相关的生活质量:2013-2017 年全国健康访谈调查。
BMC Public Health. 2023 Sep 4;23(1):1710. doi: 10.1186/s12889-023-16168-8.
2
Multidisciplinary care for patients with HCC: a systematic review and meta-analysis.多学科治疗肝细胞癌患者:系统评价和荟萃分析。
Hepatol Commun. 2023 Apr 26;7(5). doi: 10.1097/HC9.0000000000000143. eCollection 2023 May 1.
3
Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study.
患者报告结局在肝硬化中的作用。
Am J Gastroenterol. 2025 May 20;120(8):1708-1719. doi: 10.14309/ajg.0000000000003551.
社会决定因素对 HCC 和胆管癌死亡率的影响:基于人群的队列研究。
Hepatol Commun. 2023 Feb 9;7(3):e0058. doi: 10.1097/HC9.0000000000000058. eCollection 2023 Mar 1.
4
Cumulative Social Disadvantage and All-Cause Mortality in the United States: Findings from a National Study.累积社会劣势与美国全因死亡率:一项全国性研究的结果。
Popul Health Manag. 2022 Dec;25(6):789-797. doi: 10.1089/pop.2022.0184. Epub 2022 Dec 5.
5
Association of Cumulative Social Risk and Social Support With Receipt of Chemotherapy Among Patients With Advanced Colorectal Cancer.累积社会风险与社会支持与晚期结直肠癌患者接受化疗的关系。
JAMA Netw Open. 2021 Jun 1;4(6):e2113533. doi: 10.1001/jamanetworkopen.2021.13533.
6
Assessing healthcare access using the Levesque's conceptual framework- a scoping review.使用 Levesque 的概念框架评估医疗保健可及性 - 范围综述。
Int J Equity Health. 2021 May 7;20(1):116. doi: 10.1186/s12939-021-01416-3.
7
Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.肝细胞癌发病率、分期和生存率的差异:一项大型基于人群的研究。
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1193-1199. doi: 10.1158/1055-9965.EPI-20-1088. Epub 2021 Mar 18.
8
Social Determinants of Health and Race Disparities in Kidney Transplant.健康的社会决定因素与肾脏移植中的种族差异
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):262-274. doi: 10.2215/CJN.04860420. Epub 2021 Jan 28.
9
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
10
Addressing Social Needs in Health Care Settings: Evidence, Challenges, and Opportunities for Public Health.在医疗保健环境中满足社会需求:公共卫生的证据、挑战和机遇。
Annu Rev Public Health. 2021 Apr 1;42:329-344. doi: 10.1146/annurev-publhealth-090419-102204. Epub 2021 Dec 16.